Luteinizing hormone-releasing hormone receptor agonists and antagonists in prostate cancer: effects on long-term survival and combined therapy with next-generation hormonal agents

Prostate cancer is a leading cause of cancer-related death in men worldwide. Luteinizing hormone-releasing hormone receptor (LHRH-R) agonists and antagonists are known to achieve castration-level testosterone suppression; however, long-term data comparing the survival benefits of these therapies are...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Jinge Zhao, Junru Chen, Guangxi Sun, Pengfei Shen, Hao Zeng
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	China Anti-Cancer Association 2024-11-01
Saila:	Cancer Biology & Medicine
Gaiak:	luteinizing hormone-releasing hormone receptor agonists luteinizing hormone-releasing hormone receptor antagonists prostate cancer long-term survival next-generation hormonal agents
Sarrera elektronikoa:	https://www.cancerbiomed.org/content/21/11/1012
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!